About KOM agency
KOM Agency is a full services communication agency dedicated to healthcare and life sciences pioneers.
Who we are
Jean M. GRANGEON MBA
Biologist, Director & Founder
Cédric BLANPAIN MD, PhD
ULB, Volunteer Consultant
Valentina GRECO PhD, PI, HHMI Faculty Scholar
Yale University, Volunteer Consultant
Heather McCAULEY, PhD
CCHMC, Volunteer Consultant
What we do
Brainpowered by science communication experts, KOM agency provides tailor-made support for funding applications to individuals and cooperative training & research programs – best strategy & operations consulting services to academic and non-academic project leaders (translational research, growing biotech & medtech and pharma).
Communication tools and services for researchers.
Supporting EU consortium and research organizations.
Customized online solutions to share your discoveries.
Visual ID is the DNA of your communication projects, it reinforces the consistency of your message.
From the delivery of your banner stand in Hong Kong to the printing of your business cards, it’s all about KOM!
2D / 3D illustration design and production to highlight your publications and funding applications.
Excellence in imaging. Your science deserves a Pro.
Professional video producers get you under the spotlights to create compelling visual contents of your story.
Your high-profile publication is not covered in the press as you expected? It’s time to add KOM to your projects.
KOM is your social eyes and ears, directly managing and scaling your audience on any channel (Twitter, LinkedIn, FB, Instagram, Youtube…).
KOM is partnering with
ENHPATHY – Sklodowska-Curie Innovative Training Network (ITN)
KOM Agency is a proud partner of ENHPATHY, a multidisciplinary science consortium bringing together a world-leading expertise on enhancer biology, epigenomics, bioinformatics and medical genetics to increase scientific knowledge on the molecular basis of human enhanceropathies and to open new diagnostic and therapeutic avenues for patients.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860002
CRYOSTEM – A national cohort focusing on hematopoietic stem cell transplantation complications
A collection unique in Europe – Launched within the framework of Investments for the Future by the National Research Agency (ANR), at the heart of the French Government’s Plan Cancer and supported by the National Cancer Institute (INCa), the CRYOSTEM’s project was initiated in 2011 under the auspices of the Francophone Society of Marrow Transplantations and Cellular Therapy (SFGM-TC) to accelerate research in the area of complications of Hematopoietic Stem Cell Transplantation (HSCT), previously called bone marrow transplantation.
The HTC Project endowment fund – To give bone marrow transplant patients a real chance to make a fresh start.
Of 24 000 transplanted patients each year in Europe for serious blood diseases or major immunodeficiency, 50% suffer, in the short or medium term, from infectious, pulmonary, cardiac or dermatological complications, 25 % face severe and even fatal complications. By supporting the HTC Project Endowment Fund you empower scientists from around the world to develop innovative research projects to better understand, predict and treat these complications.
Each donation is important to investigate the complexity of the transplant biological mechanisms and control the risk of complications. Together we can give bone marrow transplant patients a real chance to make a fresh start.